Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | APEX1 | P27695 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | FAAH | O00519 | 3/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11523374 | 1.00 | TSHR (0.65) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL27552938 | 1.00 | TSHR (0.65) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL29218362 | 1.00 | TSHR (0.65) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL10925276 | 0.98 | TSHR (0.61) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL1949649 | 0.92 | TSHR (0.58) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL28038572 | 0.91 | TSHR (0.56) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL5836895 | 0.87 | TSHR (0.67) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL9170446 | 0.87 | TSHR (0.67) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL8699776 | 0.87 | TSHR (0.67) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL22554404 | 0.86 | TSHR (0.83) | TSHRPOLBAPEX1HTTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1592786-B8 | DIAGNOSIS AND TREATMENT OF MULTIPLE SULFATASE DEFICIENCY AND OTHER SULFATASE DEFICIENCIES USING A FORMYLGLYCINE GENERATING ENZYME (FGE) | SHIRE HUMAN GENETIC THERAPIES (US) | 2012-03-21 | — | — | EP | disclosed |
| EP-2217701-A2 | GLUCAGON ANTAGONISTS | Indiana University Research and Technology Corporation (US) | 2010-08-18 | — | — | EP | disclosed |
| WO-2009058662-A2 | GLUCAGON ANTAGONISTS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2009-05-07 | — | — | WO | disclosed |
| WO-2009047799-A1 | HIGH DOSE SOLID UNIT ORAL PHARMACEUTICAL DOSAGE FORM OF MYCOPHENOLATE SODIUM AND PROCESS FOR MAKING SAME | PANACEA BIOTEC LIMITED (IN) | 2009-04-16 | — | — | WO | disclosed |
| WO-2006062608-A2 | TUNABLE VEHICLE STRUCTURAL MEMBERS AND METHODS FOR SELECTIVELY CHANGING THE MECHANICAL PROPERTIES THERETO | GENERAL MOTORS CORPORATION (US) | 2006-06-15 | — | — | WO | disclosed |
| EP-1592786-A2 | DIAGNOSIS AND TREATMENT OF MULTIPLE SULFATASE DEFICIENCY AND OTHER USING A FORMYLGLYCINE GENERATING ENZYME (FGE) | Transkaryotic Therapies, Inc. (US) | 2005-11-09 | — | — | EP | disclosed |
| WO-2004072275-A2 | DIAGNOSIS AND TREATMENT OF MULTIPLE SULFATASE DEFICIENCY AND OTHER USING A FORMYLGLYCINE GENERATING ENZYME (FGE) | TRANSKARYOTIC THERAPIES, INC. (US) | 2004-08-26 | — | — | WO | disclosed |
| EP-1328261-A2 | TREATMENT OF NEURODEGENERATIVE DISEASE | Minerva Biotechnologies Corporation (US) | 2003-07-23 | — | — | EP | disclosed |
| WO-2001078709-A2 | TREATMENT OF NEURODEGENERATIVE DISEASE | MINERVA BIOTECHNOLOGIES CORPORATION (US) | 2001-10-25 | — | — | WO | disclosed |